Navigation Links
American Oriental Bioengineering Announces September Investor Conferences Participation
Date:9/8/2009

NEW YORK, Sept. 8 /PRNewswire-Asia-FirstCall/ -- American Oriental Bioengineering, Inc. (NYSE: AOB), ("the Company" or "AOBO"), a pharmaceutical company dedicated to improving health through the development, manufacture and commercialization of a broad range of prescription and over the counter ("OTC") products, today announced the Company's participation in the following conferences:

    -- Morgan Stanley Healthcare Corporate Day, to be held September 11, 2009
       in Boston, MA.  Management will meet with institutional investors
       throughout the day.

    -- Morgan Stanley Global Healthcare Unplugged Conference, to be held
       September 14-15, 2009 in New York City. Management will meet with
       institutional investors throughout both days.

    -- Merrill Lynch/Bank of America Global Drug, Biotech & Medical Devices
       Conference, to be held September 15-17, 2009 in London. Management will
       present at 1:45pm London Time on September 16, 2009 and meet with
       institutional investors throughout all three days. A live webcast of
       the presentation will be available via the Company's website at
      http://www.bioaobo.com/ .

    -- Susquehanna Financial Group Third Annual Beijing Management Summit, to
       be held September 16-17, 2009 in Beijing, China. Management will speak
       on a panel discussion entitled, "China Pharma/Biotech Panel
       Participants," scheduled from 1:05-2:10pm Beijing Time on September 16,
       2009. In addition, management will also present at 9:45am Beijing Time
       on September 16, 2009 and meet with institutional investors throughout
       both days.

For further details, please contact your respective institutional sales representative.

About American Oriental Bioengineering, Inc.

American Oriental Bioengineering, Inc. is a pharmaceutical company dedicated to improving health through the development, manufacture and commercialization of a broad range of prescription and over the counter products.


'/>"/>
SOURCE American Oriental Bioengineering, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. American Scientific Resources To Be Exclusive Seller of Worlds Only FDA Approved Home Needle Destruction Device
2. American Oriental Bioengineerings Jinji Capsules and Boke Nasal Spray Designated Among Chinas Top Branded Drugs of 2009
3. Swedish-American Life Science Summit (SALSS) to Address Major Issues Including Healthcare Reform, Synthetic Biology and Innovative Financing for Biotechs
4. American Oriental Bioengineering Announces Change in Independent Auditor
5. What Makes a University Great? Americans Say Renowned Faculty, Top-Rank Research Center are Most Important, According to New Survey from IP Advocate
6. American Oriental Bioengineering Reports Second Quarter 2009 Financial Results
7. American Oriental Bioengineering to Report Second Quarter 2009 Financial Results on August 7, 2009
8. American Oriental Bioengineering Honorably Elected a Top 20 Most Competitive Public Pharmaceutical Company in China
9. American Mothers Seriously Concerned About Childhood Allergies, Siemens Survey Reveals
10. American Medical Informatics Association (AMIA) Submits Comments to Hit Policy Committee About Meaningful Use and Electronic Health Record Certification
11. New RISI Report Analyzes South American Tree Farm and Biomass Energy Investment Opportunities
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/10/2017)... Angeles, CA (PRWEB) , ... ... ... Inc., a development-stage cancer-focused pharmaceutical company advancing targeted antibody-drug conjugate (ADC) therapeutics, ... uses of targeted HPLN (Hybrid Polymerized Liposomal Nanoparticle), a technology developed in ...
(Date:10/10/2017)... ... 10, 2017 , ... Dr. Bob Harman, founder and CEO of VetStem ... The event entitled “Stem Cells and Their Regenerative Powers,” was held ... Harman, DVM, MPVM was joined by two human doctors: Peter B. Hanson, M.D., Chief ...
(Date:10/10/2017)... 10, 2017 SomaGenics announced the receipt of ... develop RealSeq®-SC (Single Cell), expected to be the first ... (including microRNAs) from single cells using NGS methods. The ... to accelerate development of approaches to analyze the heterogeneity ... "New techniques for measuring levels of mRNAs in individual ...
(Date:10/10/2017)... PITTSBURGH, PA (PRWEB) , ... October 10, 2017 ... ... this year’s recipients of 13 prestigious awards honoring scientists who ... be presented in a scheduled symposium during Pittcon 2018, the world’s leading conference ...
Breaking Biology Technology:
(Date:4/18/2017)... 2017  Socionext Inc., a global expert in SoC-based imaging and ... the M820, which features the company,s hybrid codec technology. A demonstration ... Probe, Inc., will be showcased during the upcoming Medtec Japan at ... the Las Vegas Convention Center April 24-27. ... Click here for an ...
(Date:4/11/2017)... BEACH GARDENS, Fla. , April 11, 2017 ... identity management and secure authentication solutions, today announced ... contract by Intelligence Advanced Research Projects Activity (IARPA) ... for IARPA,s Thor program. "Innovation has ... onset and IARPA,s Thor program will allow us ...
(Date:4/6/2017)... Forecasts by Product Type (EAC), Biometrics, Card-Based ... & Logistics, Government & Public Sector, Utilities / Energy ... Nuclear Power), Industrial, Retail, Business Organisation (BFSI), Hospitality & ... for a definitive report on the $27.9bn Access Control ... ...
Breaking Biology News(10 mins):